ClinicalTrials.gov
ClinicalTrials.gov Menu

Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00681369
Recruitment Status : Completed
First Posted : May 21, 2008
Last Update Posted : January 24, 2011
Sponsor:
Information provided by:
AstraZeneca

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : June 2007